Product Name | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) |
---|---|
CAS | 1036730-42-3 |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | $800.00 | Visible after login | |
5 mg | 3-5days | $2300.00 | Visible after login | |
10 mg | 3-5days | $4200.00 | Visible after login | |
50 mg | 3-5days | $18500.00 | Visible after login | |
100 mg | 3-5days | $34000.00 | Visible after login |
Product Name | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) |
---|---|
CAS | 1036730-42-3 |
Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.